Freedom to Operate (FTO) in Europe: Why, When and How Much (2026)

A freedom-to-operate (FTO) study is the opposite of a patentability search. Patentability asks whether your invention is new and inventive. FTO asks whether someone else's rights already cover what you plan to make, sell or market. For a US company entering Europe, the question is not only whether you can get a patent — it is whether anyone else's European patent, trade mark or design could stop you.

Why an FTO is needed. Europe is not a single IP market. A granted European patent becomes a bundle of national patents, and national courts can enforce them independently. A product cleared in the US may still infringe an EP patent validated in Germany, France or the Netherlands. Trade marks and designs are similar: an EUTM covers the EU, but national marks and common-law use remain enforceable in many member states. An FTO maps the rights that matter for your actual launch plan.

The purpose of the study. An FTO identifies active third-party rights, interprets their scope against your product or brand, and ranks the risk. The output is usually a memo with a red/amber/green view: blocking rights that require a design-around or licence, lower-risk rights to monitor, and clear lanes. It gives leadership, investors and distributors a defensible basis for the go-to-market decision.

Consequences of skipping FTO. The worst-case outcome is not a damages award — it is an injunction that stops sales across a major market, plus recall costs, destroyed inventory and terminated distribution agreements. Under the Unified Patent Court, a single injunction can now cover all participating EU states. Even a settled case is expensive: legal fees, redesign, rebranding and lost launch momentum. In M&A and fundraising, an undisclosed FTO risk can derail valuation or kill the deal.

What happens when FTO is not conducted. Most companies that skip FTO discover the problem reactively: a cease-and-desist letter, a competitor's opposition, a customs seizure, or a due-diligence finding just before closing. At that point the options narrow. A design-around may require re-engineering a finished product. A licence is priced as damage control, not a market-rate deal. And invalidity challenges — while sometimes viable — are costly, slow and never guaranteed.

Types of FTO study. The three main types mirror the three IP rights that can block a launch. Patent FTO searches active European patents, pending EP applications and national patents (and utility models in Germany, Spain and a few others) in the countries where you will manufacture or sell. Trademark FTO checks EUTM and national trade mark registers, plus common-law use and domain trading names. Design FTO searches registered Community designs and national design registers, and considers unregistered design rights in the EU and UK. For pharmaceuticals and agrochemicals, supplementary protection certificates (SPCs) are a separate FTO layer.

European-level vs national studies. A European patent FTO can be run centrally for pending EP applications and granted EP patents, but validity and infringement after grant are judged country by country. That means the value of a study depends on where the patent is validated. A lean FTO often starts with Germany, France, the UK, the Netherlands and Italy — the largest enforcement venues — and expands only if the product's commercial footprint justifies it. For trade marks and designs, a single EUTM or registered Community design can block the whole EU, so a European-level clearance is usually the first step.

What the cost depends on. The biggest drivers are the number of jurisdictions, the complexity of the product or brand, the quality of the prior-art landscape, and how deep the legal opinion needs to be. A high-level landscape search is cheaper than a claim-by-claim infringement opinion. A single-product mechanical device is cheaper to analyse than a complex CII or biotech product with hundreds of related patents. The table above gives typical attorney-fee ranges; official register searches are usually included, but specialised technical databases may be extra.

When to engage. The cheapest time to run an FTO is before the design is frozen. Early-stage FTO lets engineers design around problem patents while changes are still cheap. Late-stage FTO is still valuable, but the answers are often more expensive: redesign, licence or launch-with-risk. Most US companies commission a first FTO before beta testing in Europe, and update it before each major product refresh or market expansion.

Who should conduct it. Patent FTO should be handled by a European Patent Attorney with experience in the relevant technology, because claim construction and national-validation status are easy to misread. Trade mark and design clearance can be led by a European trademark attorney. For US companies, the same firm can coordinate both streams and deliver a single launch-risk memo. A fuller look at EU trade mark clearance is in the EU trademark search and registration guide.

The bottom line. FTO is not a box-ticking exercise. It is a commercial risk tool: it tells you whether the European market is open for your product or brand, on what terms, and at what cost. Skipping it does not make the risk disappear; it just moves the discovery to a moment when your options are fewer and more expensive. If you are planning a European launch and need a scoped FTO or portfolio-risk review, see the European Patent Attorney service page for a fixed-fee estimate.